RA Patients More Likely to Abandon Remicade (CME/CE)

(MedPage Today) -- Discontinuation rates higher for infliximab versus adalimumab and etanercept in rheumatoid arthritis.

Source: MedPage Today Geriatrics - January 14, 2015 Category: Geriatrics Source Type: news